Abstract
Providing effective information about drug risks and benefits has become a major challenge for health professionals, as many people are ill equipped to understand, retain and use the information effectively. This paper reviews the growing evidence that peoples understanding (and health behaviour) is not only affected by the content of medicines information, but also by the particular way in which it is presented. Such presentational factors include whether information is presented verbally or numerically, framed positively or negatively, whether risk reductions are described in relative or absolute terms (and baseline information included), and whether information is personalized or tailored in any way. It also looks at how understanding is affected by the order in which information is presented, and the way in which it is processed. The paper concludes by making a number of recommendations for providers of medicines information, about both the content and presentation of such information, that should enhance safe and effective medicines usage.
Keywords: Medicines information, risk communication, medicine benefits, probability descriptors, framing, message tailoring
Current Drug Safety
Title: Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products
Volume: 1 Issue: 1
Author(s): Dianne C. Berry
Affiliation:
Keywords: Medicines information, risk communication, medicine benefits, probability descriptors, framing, message tailoring
Abstract: Providing effective information about drug risks and benefits has become a major challenge for health professionals, as many people are ill equipped to understand, retain and use the information effectively. This paper reviews the growing evidence that peoples understanding (and health behaviour) is not only affected by the content of medicines information, but also by the particular way in which it is presented. Such presentational factors include whether information is presented verbally or numerically, framed positively or negatively, whether risk reductions are described in relative or absolute terms (and baseline information included), and whether information is personalized or tailored in any way. It also looks at how understanding is affected by the order in which information is presented, and the way in which it is processed. The paper concludes by making a number of recommendations for providers of medicines information, about both the content and presentation of such information, that should enhance safe and effective medicines usage.
Export Options
About this article
Cite this article as:
Berry C. Dianne, Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products, Current Drug Safety 2006; 1 (1) . https://dx.doi.org/10.2174/157488606775252638
DOI https://dx.doi.org/10.2174/157488606775252638 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
TGF-β, Eosinophils and IL-13 in Allergic Airway Remodeling: A Critical Appraisal with Therapeutic Considerations
Inflammation & Allergy - Drug Targets (Discontinued) Genetic Determinants of Severe Respiratory Syncytial Virus Infection and Post-Bronchiolitis Wheeze: A Systematic Review
Current Respiratory Medicine Reviews Genetic Susceptibility to Autoimmune Disorders: Clues from Gene Association and Gene Expression Studies
Current Molecular Medicine Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Clinical Potential of VIP by Modified Pharmaco-kinetics and Delivery Mechanisms
Endocrine, Metabolic & Immune Disorders - Drug Targets Analysis of Trends and Opportunities of Anti-Allergy Patents in China from 1998 to 2008
Recent Patents on Inflammation & Allergy Drug Discovery The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug
Letters in Drug Design & Discovery Asthma in Adolescence: How Does this Differ from Childhood and Adult Asthma?
Current Pediatric Reviews NOS: Molecular Mechanisms, Clinical Aspects, Therapeutic and Monitoring Approaches
Current Drug Targets - Inflammation & Allergy Why are People with “Poor Lung Function” At Increased Atherothrombotic Risk?A Critical Review with Potential Therapeutic Indications
Current Vascular Pharmacology Recent Progress in Rational Drug Design of Neuraminidase Inhibitors
Current Medicinal Chemistry Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Chemical Biology: Past, Present and Future
Current Chemical Biology Tryptophan Catabolism in IDO+ Plasmacytoid Dendritic Cells
Current Drug Metabolism Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
Current Pharmaceutical Biotechnology Electrochemical Oxidation of Prednisolone at Glassy Carbon Electrode and Its Quantitative Determination in Human Serum and Tablets by Osteryoung Square Wave Voltammetry
Current Analytical Chemistry Substance P: Structure, Function, and Therapeutics
Current Topics in Medicinal Chemistry Advances of Knowledge on Allergic Inflammation and the Oral Mucosa
Recent Patents on Inflammation & Allergy Drug Discovery Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design